Parkinson's Disease Clinical Trials in Cleveland, Ohio

7 studies are recruiting for parkinson's disease in Cleveland, Ohio right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

   The purpose of this registry is to compile characteristics of world-wide outcomes for the use of Boston Scientific's commercially available Vercise DBS System in the treatment of Parkinson's disease. The utilization of Image Guided Programming (IGP), and other commercially available programming fea…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Cleveland Clinic Foundation, Cleveland, Ohio

   Locations

   86 in total

   Run by

   Boston Scientific Corporation

   See if you can join NCT02071134 on ClinicalTrials.gov

2. Parkinson's Foundation PD GENEration Genetic Registry

   Development of a central repository for PD-related genomic data for future research.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Case Western Reserve University, Cleveland, Ohio

   Locations

   70 in total

   Run by

   Parkinson's Foundation

   See if you can join NCT04994015 on ClinicalTrials.gov

3. A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications

   This is an observational study in which data are collected and studied from Parkinson's disease patients who have movement symptoms despite taking standard Parkinson's medications. In observational studies, observations are made without any changes to the participant's healthcare or treatment plan.…

   Stage

   Not phased

   Ages

   45 to 75

   Site

   Cleveland Clinic, Cleveland, Ohio

   Locations

   27 in total

   Run by

   Bayer

   See if you can join NCT07330258 on ClinicalTrials.gov

4. A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

   The purpose of this study is to evaluate the efficacy, safety, and pharmacokinetics (PK) of prasinezumab compared with placebo in participants with early-stage Parkinson's disease (PD) on stable symptomatic monotherapy with levodopa.

   Stage

   Phase 3

   Ages

   50 to 85

   Site

   Cleveland Clinic, Cleveland, Ohio

   Locations

   192 in total

   Run by

   Hoffmann-La Roche

   See if you can join NCT07174310 on ClinicalTrials.gov

5. Neural Mechanisms of Aerobic Exercise Benefits in PD With DBS

   This study is focused on people with Parkinson's disease who already have deep brain stimulation devices. The goal is to understand how aerobic exercise, specifically forced vs voluntary cycling, affects movement, thinking, and brain activity in these individuals. Parkinson's disease is a progressi…

   Stage

   Phase 2

   Ages

   18 and older

   Site

   Cleveland Clinic, Cleveland, Ohio

   Run by

   The Cleveland Clinic

   See if you can join NCT07442747 on ClinicalTrials.gov

6. Optimizing Deep Brain Stimulation to Improve Visuomotor Function in Parkinson's Disease

   Inability to align and refocus the eyes on the objects at different depths, i.e., vergence impairment and strabismus, frequently affects the quality of life in patients with Parkinson's disease. The investigators study aims to understand the location-specific effects of subthalamic region deep brai…

   Stage

   Not phased

   Ages

   Any age

   Site

   Louis Stokes VA Medical Center, Cleveland, OH, Cleveland, Ohio

   Run by

   VA Office of Research and Development

   See if you can join NCT06857851 on ClinicalTrials.gov

7. Deep Brain Stimulation for Visuomotor Function in Parkinson's Disease

   Inability to align and refocus the eyes on the objects at different depths, i.e., vergence impairment, frequently affects the quality of life in patients with Parkinson's disease. Our study aims to understand the location-specific effects of subthalamic region deep brain stimulation on vergence by …

   Stage

   Not phased

   Ages

   Any age

   Site

   Louis Stokes VA Medical Center, Cleveland, OH, Cleveland, Ohio

   Run by

   VA Office of Research and Development

   See if you can join NCT05400499 on ClinicalTrials.gov